Alx Oncology Holdings Inc SEC filings ALXO
Alx Oncology Holdings Inc has 421 filings in SEC EDGAR's recent list, going back to May 5, 2020. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 15, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Jun 30, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Jun 26, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Results of operations
|
May 8, 2026 | May 8, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 13, 2026 | Apr 13, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2026 | Feb 27, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 30, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Other events
|
Jan 30, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 21, 2026 | Jan 21, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2025 | Nov 7, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Sep 12, 2025 | Sep 11, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Other events
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Listing notice
|
Apr 25, 2025 | Apr 23, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2025 | Mar 6, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change
|
Mar 5, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Jan 22, 2025 | Jan 16, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 17, 2025 | Jan 16, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Nov 14, 2024 | Nov 8, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 7, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 4, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Aug 6, 2024 | Aug 5, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2024 | Jun 12, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Officer or director change
|
May 2, 2024 | Apr 28, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 7, 2024 | Mar 7, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 26, 2023 | Dec 22, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 6, 2023 | Oct 4, 2023 |
| 8-K |
Current report
Results of operations
|
Oct 4, 2023 | Oct 4, 2023 |
| 8-K |
Current report
Other events
|
Oct 4, 2023 | Oct 3, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Sep 6, 2023 | Sep 1, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 20, 2023 | Jun 16, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2023 | Mar 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 29, 2022 | Nov 28, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Oct 31, 2022 | Oct 27, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2022 | Jun 14, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 12, 2022 | Apr 11, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Material agreement
|
Dec 17, 2021 | Dec 17, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2021 | Nov 11, 2021 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Oct 7, 2021 | Oct 4, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2021 | Aug 26, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2021 | Jun 10, 2021 |
| 8-K |
Current report
Results of operations
|
May 17, 2021 | May 17, 2021 |
| 8-K |
Current report
Officer or director change
|
May 4, 2021 | May 3, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 25, 2021 | Mar 22, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2021 | Mar 18, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 15, 2021 | Mar 11, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 23, 2020 | Dec 22, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2020 | Nov 12, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 27, 2020 | Aug 27, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 21, 2020 | Jul 21, 2020 |
Showing 64 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ALXO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1810182
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.